https://orcid.org/0000-0002-0653-0630
References
- Wang S, Chen L, Fang J, et al. Comparison of the pregnancy and obstetric outcomes between single cleavage-stage embryo transfer and single blastocyst transfer by time-lapse selection of embryos. Gynecol Endocrinol. 2019;35(9):792–795.
- Lisonkova S, Sabr Y, Mayer C, et al. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124(4):771–781.
- Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
- Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991–4995.
- Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445–453.
- Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003;187(Suppl. 2):S397–S401.
- Arts RJW, Joosten LAB, van der Meer JWM, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 2013;93(2):209–215.
- Sun W, Cui B, Hong F, et al. Establishment of ApoE-knockout mouse model of preeclampsia and relevant mechanisms. Exp Ther Med. 2016;12(4):2634–2638.
- Kulikova GV, Nizyaeva NV, Nagovitsina MN, et al. Specific features of TLR4 expression in structural elements of placenta in patients with preeclampsia. Bull Exp Biol Med. 2016;160(5):718–721.
- Tammaro A, Derive M, Gibot S, et al. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81–95.
- Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21(1):38–46.
- Roe K, Gibot S, Verma S. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Front Microbiol. 2014;5:627.
- Viechtbauer W, Smits L, Kotz D, et al. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015;68(11):1375–1379.
- Gauster M, Moser G, Orendi K, et al. Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Placenta. 2009;30:49–54.
- Youssef RE, Ledingham MA, Bollapragada SS, et al. The role of toll-like receptors (TLR-2 and-4) and triggering receptor expressed on myeloid cells 1 (TREM-1) in human term and preterm labor. Reprod Sci. 2009;16(9):843–856.
- Gingras M-C, Lapillonne H, Margolin JF. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Mol Immunol. 2002;38(11):817–824.
- Varkonyi T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011;32:S21–S29.
- Nishizawa H, Ota S, Suzuki M, et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol. 2011;9(1):107.
- Lim R, Barker G, Lappas M. TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization. Reprod Sci. 2014;21(5):562–572.